Bank of Nova Scotia Invests $228,000 in Option Care Health, Inc. (NASDAQ:OPCH)

Bank of Nova Scotia acquired a new stake in Option Care Health, Inc. (NASDAQ:OPCH - Free Report) in the 4th quarter, according to its most recent disclosure with the SEC. The fund acquired 9,843 shares of the company's stock, valued at approximately $228,000.

A number of other institutional investors have also recently modified their holdings of the stock. Barclays PLC grew its stake in Option Care Health by 180.1% during the third quarter. Barclays PLC now owns 310,194 shares of the company's stock worth $9,708,000 after purchasing an additional 199,454 shares during the period. Central Pacific Bank Trust Division boosted its stake in shares of Option Care Health by 6.9% in the 4th quarter. Central Pacific Bank Trust Division now owns 10,079 shares of the company's stock worth $234,000 after buying an additional 650 shares during the last quarter. Nordea Investment Management AB grew its stake in Option Care Health by 6.0% in the 4th quarter. Nordea Investment Management AB now owns 94,641 shares of the company's stock valued at $2,165,000 after purchasing an additional 5,365 shares during the period. Harbor Capital Advisors Inc. raised its position in Option Care Health by 2.7% in the fourth quarter. Harbor Capital Advisors Inc. now owns 213,155 shares of the company's stock worth $4,945,000 after acquiring an additional 5,595 shares during the period. Finally, Graypoint LLC bought a new stake in shares of Option Care Health in the 4th quarter worth approximately $1,161,000. 98.05% of the stock is currently owned by institutional investors.

Option Care Health Stock Down 0.6 %

Shares of Option Care Health stock traded down $0.19 during trading on Friday, hitting $32.09. 1,835,227 shares of the stock traded hands, compared to its average volume of 1,795,968. The firm has a market cap of $5.27 billion, a P/E ratio of 26.96, a price-to-earnings-growth ratio of 2.30 and a beta of 1.07. The stock's fifty day simple moving average is $33.33 and its 200 day simple moving average is $28.66. Option Care Health, Inc. has a 52-week low of $21.39 and a 52-week high of $35.53. The company has a current ratio of 1.73, a quick ratio of 1.32 and a debt-to-equity ratio of 0.77.

Analysts Set New Price Targets

OPCH has been the topic of several research analyst reports. Jefferies Financial Group upgraded shares of Option Care Health from a "hold" rating to a "buy" rating and upped their price objective for the stock from $26.00 to $35.00 in a research report on Thursday, January 23rd. JMP Securities restated a "market outperform" rating and issued a $30.00 price objective (down previously from $31.00) on shares of Option Care Health in a research report on Friday, January 10th. Bank of America upgraded shares of Option Care Health from a "neutral" rating to a "buy" rating and lifted their price target for the company from $26.00 to $33.00 in a report on Monday, January 13th. Barrington Research upped their target price on Option Care Health from $33.00 to $38.00 and gave the stock an "outperform" rating in a report on Thursday, February 27th. Finally, JPMorgan Chase & Co. boosted their price objective on shares of Option Care Health from $40.00 to $41.00 and gave the stock an "overweight" rating in a research note on Thursday, March 6th. Two research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and a consensus target price of $33.00.

Insiders Place Their Bets

In other Option Care Health news, insider Michael Bavaro sold 30,996 shares of Option Care Health stock in a transaction dated Friday, February 28th. The shares were sold at an average price of $33.26, for a total transaction of $1,030,926.96. Following the transaction, the insider now directly owns 44,974 shares of the company's stock, valued at $1,495,835.24. The trade was a 40.80 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. 0.64% of the stock is owned by insiders.

Option Care Health Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.